BridgeMD
New treatment option for Tourette Syndrome
Official title Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome
ClinicalTrials.gov ID: NCT06909656
What this study is testing
- What it's testing
- Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the occurrence of involuntary movements (motor tics) and vocalizations (phonic tics). The onset of TS is usually in childhood, and the prevalence of TS is estimated between 0.3 and 0.9% before the age of 18, decreasing progressively after that age.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- Patient at least 16 years old.
- Disabling and drug-resistant Tourette's syndrome.
- Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management.
- Normal brain MRI.
- Subject affiliated or beneficiary of a social security system.
You likely can't join if
- Major depressive syndrome (Beck Depression Inventory (BDI-II) \> 20).
- MRI showing significant brain atrophy or significant hyperintensities.
- Pregnant or nursing mothers.
- Person unable to give personal consent.
- Person subject to a legal protection measure (curatorship, guardianship) or placed under court protection.
- Patient included in another research protocol with an interdiction of participation to another research or in an exclusion period
See the full eligibility criteria
- Patient at least 16 years old.
- Disabling and drug-resistant Tourette's syndrome.
- Receiving deep brain stimulation treatment with implantation of the PERCEPT™ Device as part of their medical management.
- Normal brain MRI.
- Subject affiliated or beneficiary of a social security system.
- Free and informed consent of the patient and, for minors, of the minor and at least one parental authority.
- Major depressive syndrome (Beck Depression Inventory (BDI-II) \> 20).
- MRI showing significant brain atrophy or significant hyperintensities.
- Pregnant or nursing mothers.
- Person unable to give personal consent.
- Person subject to a legal protection measure (curatorship, guardianship) or placed under court protection.
- Patient included in another research protocol with an interdiction of participation to another research or in an exclusion period
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.